Global Cancer Supportive Care Medicine Market Research Report 2017
In this report, the global Cancer Supportive Care Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Supportive Care Medicine in these regions, from 2012 to 2022 (forecast), covering
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Supportive Care Medicine in these regions, from 2012 to 2022 (forecast), covering
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Amgen
- Helsinn Healthcare
- Johnson &Johnson
- Merck
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Heron Therapeutics
- Kyowa Hakko Kirin
- Novartis
- TESARO
- Teva Pharmaceutical Industries
- Antiemetic Drugs
- Erythropoietin-Stimulating Agents
- Granulocyte-Stimulating Agents
- Analgesics
- Others
- Chemotherapy-Induced Anemia
- CINV
- Bone Metastasis
- Cancer Pain
- Other
Global Cancer Supportive Care Medicine Market Research Report 2017
1 CANCER SUPPORTIVE CARE MEDICINE MARKET OVERVIEW
1.1 Product Overview and Scope of Cancer Supportive Care Medicine
1.2 Cancer Supportive Care Medicine Segment by Type (Product Category)
1.2.1 Global Cancer Supportive Care Medicine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Cancer Supportive Care Medicine Production Market Share by Type (Product Category) in 2016
1.2.3 Antiemetic Drugs
1.2.4 Erythropoietin-Stimulating Agents
1.2.5 Granulocyte-Stimulating Agents
1.2.6 Analgesics
1.2.7 Others
1.3 Global Cancer Supportive Care Medicine Segment by Application
1.3.1 Cancer Supportive Care Medicine Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Chemotherapy-Induced Anemia
1.3.3 CINV
1.3.4 Bone Metastasis
1.3.5 Cancer Pain
1.3.6 Other
1.4 Global Cancer Supportive Care Medicine Market by Region (2012-2022)
1.4.1 Global Cancer Supportive Care Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cancer Supportive Care Medicine (2012-2022)
1.5.1 Global Cancer Supportive Care Medicine Revenue Status and Outlook (2012-2022)
1.5.2 Global Cancer Supportive Care Medicine Capacity, Production Status and Outlook (2012-2022)
2 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Cancer Supportive Care Medicine Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Cancer Supportive Care Medicine Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Cancer Supportive Care Medicine Production and Share by Manufacturers (2012-2017)
2.2 Global Cancer Supportive Care Medicine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cancer Supportive Care Medicine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cancer Supportive Care Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Supportive Care Medicine Market Competitive Situation and Trends
2.5.1 Cancer Supportive Care Medicine Market Concentration Rate
2.5.2 Cancer Supportive Care Medicine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 GLOBAL CANCER SUPPORTIVE CARE MEDICINE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)
3.1 Global Cancer Supportive Care Medicine Capacity and Market Share by Region (2012-2017)
3.2 Global Cancer Supportive Care Medicine Production and Market Share by Region (2012-2017)
3.3 Global Cancer Supportive Care Medicine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 GLOBAL CANCER SUPPORTIVE CARE MEDICINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)
4.1 Global Cancer Supportive Care Medicine Consumption by Region (2012-2017)
4.2 North America Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.4 China Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.7 India Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
5 GLOBAL CANCER SUPPORTIVE CARE MEDICINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 Global Cancer Supportive Care Medicine Production and Market Share by Type (2012-2017)
5.2 Global Cancer Supportive Care Medicine Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Supportive Care Medicine Price by Type (2012-2017)
5.4 Global Cancer Supportive Care Medicine Production Growth by Type (2012-2017)
6 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MARKET ANALYSIS BY APPLICATION
6.1 Global Cancer Supportive Care Medicine Consumption and Market Share by Application (2012-2017)
6.2 Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MANUFACTURERS PROFILES/ANALYSIS
7.1 Amgen
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Amgen Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Helsinn Healthcare
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Johnson &Johnson
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Johnson &Johnson Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Merck
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Merck Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 F. Hoffmann-La Roche
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Heron Therapeutics
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Heron Therapeutics Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Kyowa Hakko Kirin
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Novartis
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Novartis Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 TESARO
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 TESARO Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Teva Pharmaceutical Industries
8 CANCER SUPPORTIVE CARE MEDICINE MANUFACTURING COST ANALYSIS
8.1 Cancer Supportive Care Medicine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Cancer Supportive Care Medicine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2015
9.4 Downstream Buyers
10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MARKET FORECAST (2017-2022)
12.1 Global Cancer Supportive Care Medicine Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Cancer Supportive Care Medicine Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Cancer Supportive Care Medicine Price and Trend Forecast (2017-2022)
12.2 Global Cancer Supportive Care Medicine Production, Consumption, Import and Export Forecast by Region (2017-2022)
12.2.1 North America Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cancer Supportive Care Medicine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cancer Supportive Care Medicine Consumption Forecast by Application (2017-2022)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 CANCER SUPPORTIVE CARE MEDICINE MARKET OVERVIEW
1.1 Product Overview and Scope of Cancer Supportive Care Medicine
1.2 Cancer Supportive Care Medicine Segment by Type (Product Category)
1.2.1 Global Cancer Supportive Care Medicine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Cancer Supportive Care Medicine Production Market Share by Type (Product Category) in 2016
1.2.3 Antiemetic Drugs
1.2.4 Erythropoietin-Stimulating Agents
1.2.5 Granulocyte-Stimulating Agents
1.2.6 Analgesics
1.2.7 Others
1.3 Global Cancer Supportive Care Medicine Segment by Application
1.3.1 Cancer Supportive Care Medicine Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Chemotherapy-Induced Anemia
1.3.3 CINV
1.3.4 Bone Metastasis
1.3.5 Cancer Pain
1.3.6 Other
1.4 Global Cancer Supportive Care Medicine Market by Region (2012-2022)
1.4.1 Global Cancer Supportive Care Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cancer Supportive Care Medicine (2012-2022)
1.5.1 Global Cancer Supportive Care Medicine Revenue Status and Outlook (2012-2022)
1.5.2 Global Cancer Supportive Care Medicine Capacity, Production Status and Outlook (2012-2022)
2 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Cancer Supportive Care Medicine Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Cancer Supportive Care Medicine Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Cancer Supportive Care Medicine Production and Share by Manufacturers (2012-2017)
2.2 Global Cancer Supportive Care Medicine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cancer Supportive Care Medicine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cancer Supportive Care Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Supportive Care Medicine Market Competitive Situation and Trends
2.5.1 Cancer Supportive Care Medicine Market Concentration Rate
2.5.2 Cancer Supportive Care Medicine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 GLOBAL CANCER SUPPORTIVE CARE MEDICINE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)
3.1 Global Cancer Supportive Care Medicine Capacity and Market Share by Region (2012-2017)
3.2 Global Cancer Supportive Care Medicine Production and Market Share by Region (2012-2017)
3.3 Global Cancer Supportive Care Medicine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 GLOBAL CANCER SUPPORTIVE CARE MEDICINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)
4.1 Global Cancer Supportive Care Medicine Consumption by Region (2012-2017)
4.2 North America Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.4 China Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
4.7 India Cancer Supportive Care Medicine Production, Consumption, Export, Import (2012-2017)
5 GLOBAL CANCER SUPPORTIVE CARE MEDICINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 Global Cancer Supportive Care Medicine Production and Market Share by Type (2012-2017)
5.2 Global Cancer Supportive Care Medicine Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Supportive Care Medicine Price by Type (2012-2017)
5.4 Global Cancer Supportive Care Medicine Production Growth by Type (2012-2017)
6 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MARKET ANALYSIS BY APPLICATION
6.1 Global Cancer Supportive Care Medicine Consumption and Market Share by Application (2012-2017)
6.2 Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MANUFACTURERS PROFILES/ANALYSIS
7.1 Amgen
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Amgen Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Helsinn Healthcare
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Johnson &Johnson
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Johnson &Johnson Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Merck
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Merck Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 F. Hoffmann-La Roche
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Heron Therapeutics
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Heron Therapeutics Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Kyowa Hakko Kirin
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Novartis
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Novartis Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 TESARO
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 TESARO Cancer Supportive Care Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Teva Pharmaceutical Industries
8 CANCER SUPPORTIVE CARE MEDICINE MANUFACTURING COST ANALYSIS
8.1 Cancer Supportive Care Medicine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Cancer Supportive Care Medicine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2015
9.4 Downstream Buyers
10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 GLOBAL CANCER SUPPORTIVE CARE MEDICINE MARKET FORECAST (2017-2022)
12.1 Global Cancer Supportive Care Medicine Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Cancer Supportive Care Medicine Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Cancer Supportive Care Medicine Price and Trend Forecast (2017-2022)
12.2 Global Cancer Supportive Care Medicine Production, Consumption, Import and Export Forecast by Region (2017-2022)
12.2.1 North America Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Cancer Supportive Care Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cancer Supportive Care Medicine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cancer Supportive Care Medicine Consumption Forecast by Application (2017-2022)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Picture of Cancer Supportive Care Medicine
Figure Global Cancer Supportive Care Medicine Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Cancer Supportive Care Medicine Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Antiemetic Drugs
Table Major Manufacturers of Antiemetic Drugs
Figure Product Picture of Erythropoietin-Stimulating Agents
Table Major Manufacturers of Erythropoietin-Stimulating Agents
Figure Product Picture of Granulocyte-Stimulating Agents
Table Major Manufacturers of Granulocyte-Stimulating Agents
Figure Product Picture of Analgesics
Table Major Manufacturers of Analgesics
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Cancer Supportive Care Medicine Consumption (K Pcs) by Applications (2012-2022)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Applications in 2016
Figure Chemotherapy-Induced Anemia Examples
Table Key Downstream Customer in Chemotherapy-Induced Anemia
Figure CINV Examples
Table Key Downstream Customer in CINV
Figure Bone Metastasis Examples
Table Key Downstream Customer in Bone Metastasis
Figure Cancer Pain Examples
Table Key Downstream Customer in Cancer Pain
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Cancer Supportive Care Medicine Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Supportive Care Medicine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Cancer Supportive Care Medicine Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Cancer Supportive Care Medicine Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Cancer Supportive Care Medicine Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Cancer Supportive Care Medicine Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Cancer Supportive Care Medicine Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Cancer Supportive Care Medicine Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Cancer Supportive Care Medicine Major Players Product Production (K Pcs) (2012-2017)
Table Global Cancer Supportive Care Medicine Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Cancer Supportive Care Medicine Production Share by Manufacturers (2012-2017)
Figure 2016 Cancer Supportive Care Medicine Production Share by Manufacturers
Figure 2017 Cancer Supportive Care Medicine Production Share by Manufacturers
Figure Global Cancer Supportive Care Medicine Major Players Product Revenue (Million USD) (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Cancer Supportive Care Medicine Revenue Share by Manufacturers
Table 2017 Global Cancer Supportive Care Medicine Revenue Share by Manufacturers
Table Global Market Cancer Supportive Care Medicine Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Cancer Supportive Care Medicine Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Cancer Supportive Care Medicine Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Supportive Care Medicine Product Category
Figure Cancer Supportive Care Medicine Market Share of Top 3 Manufacturers
Figure Cancer Supportive Care Medicine Market Share of Top 5 Manufacturers
Table Global Cancer Supportive Care Medicine Capacity (K Pcs) by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Capacity Market Share by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Capacity Market Share by Region (2012-2017)
Figure 2016 Global Cancer Supportive Care Medicine Capacity Market Share by Region
Table Global Cancer Supportive Care Medicine Production by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Production (K Pcs) by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Production Market Share by Region (2012-2017)
Figure 2016 Global Cancer Supportive Care Medicine Production Market Share by Region
Table Global Cancer Supportive Care Medicine Revenue (Million USD) by Region (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue Market Share by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Revenue Market Share by Region (2012-2017)
Table 2016 Global Cancer Supportive Care Medicine Revenue Market Share by Region
Figure Global Cancer Supportive Care Medicine Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) Market by Region (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption Market Share by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Region (2012-2017)
Figure 2016 Global Cancer Supportive Care Medicine Consumption (K Pcs) Market Share by Region
Table North America Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Cancer Supportive Care Medicine Production (K Pcs) by Type (2012-2017)
Table Global Cancer Supportive Care Medicine Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Supportive Care Medicine by Type (2012-2017)
Figure 2016 Production Market Share of Cancer Supportive Care Medicine by Type
Table Global Cancer Supportive Care Medicine Revenue (Million USD) by Type (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Supportive Care Medicine by Type (2012-2017)
Figure 2016 Revenue Market Share of Cancer Supportive Care Medicine by Type
Table Global Cancer Supportive Care Medicine Price (USD/Pcs) by Type (2012-2017)
Figure Global Cancer Supportive Care Medicine Production Growth by Type (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) by Application (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption Market Share by Application (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Applications (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Application in 2016
Table Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Helsinn Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Helsinn Healthcare Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Johnson &Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson &Johnson Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Merck Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Merck Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Heron Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heron Therapeutics Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table TESARO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TESARO Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TESARO Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure TESARO Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure TESARO Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Supportive Care Medicine
Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine
Figure Cancer Supportive Care Medicine Industrial Chain Analysis
Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2016
Table Major Buyers of Cancer Supportive Care Medicine
Table Distributors/Traders List
Figure Global Cancer Supportive Care Medicine Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Supportive Care Medicine Price (Million USD) and Trend Forecast (2017-2022)
Table Global Cancer Supportive Care Medicine Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Cancer Supportive Care Medicine Production Market Share Forecast by Region (2017-2022)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Cancer Supportive Care Medicine Consumption Market Share Forecast by Region (2017-2022)
Figure North America Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Cancer Supportive Care Medicine Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Cancer Supportive Care Medicine Production (K Pcs) Forecast by Type (2017-2022)
Table Global Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Supportive Care Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Supportive Care Medicine Price Forecast by Type (2017-2022)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Cancer Supportive Care Medicine Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Figure Picture of Cancer Supportive Care Medicine
Figure Global Cancer Supportive Care Medicine Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Cancer Supportive Care Medicine Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Antiemetic Drugs
Table Major Manufacturers of Antiemetic Drugs
Figure Product Picture of Erythropoietin-Stimulating Agents
Table Major Manufacturers of Erythropoietin-Stimulating Agents
Figure Product Picture of Granulocyte-Stimulating Agents
Table Major Manufacturers of Granulocyte-Stimulating Agents
Figure Product Picture of Analgesics
Table Major Manufacturers of Analgesics
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Cancer Supportive Care Medicine Consumption (K Pcs) by Applications (2012-2022)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Applications in 2016
Figure Chemotherapy-Induced Anemia Examples
Table Key Downstream Customer in Chemotherapy-Induced Anemia
Figure CINV Examples
Table Key Downstream Customer in CINV
Figure Bone Metastasis Examples
Table Key Downstream Customer in Bone Metastasis
Figure Cancer Pain Examples
Table Key Downstream Customer in Cancer Pain
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Cancer Supportive Care Medicine Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Supportive Care Medicine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Cancer Supportive Care Medicine Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Cancer Supportive Care Medicine Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Cancer Supportive Care Medicine Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Cancer Supportive Care Medicine Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Cancer Supportive Care Medicine Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Cancer Supportive Care Medicine Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Cancer Supportive Care Medicine Major Players Product Production (K Pcs) (2012-2017)
Table Global Cancer Supportive Care Medicine Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Cancer Supportive Care Medicine Production Share by Manufacturers (2012-2017)
Figure 2016 Cancer Supportive Care Medicine Production Share by Manufacturers
Figure 2017 Cancer Supportive Care Medicine Production Share by Manufacturers
Figure Global Cancer Supportive Care Medicine Major Players Product Revenue (Million USD) (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Cancer Supportive Care Medicine Revenue Share by Manufacturers
Table 2017 Global Cancer Supportive Care Medicine Revenue Share by Manufacturers
Table Global Market Cancer Supportive Care Medicine Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Cancer Supportive Care Medicine Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Cancer Supportive Care Medicine Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Supportive Care Medicine Product Category
Figure Cancer Supportive Care Medicine Market Share of Top 3 Manufacturers
Figure Cancer Supportive Care Medicine Market Share of Top 5 Manufacturers
Table Global Cancer Supportive Care Medicine Capacity (K Pcs) by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Capacity Market Share by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Capacity Market Share by Region (2012-2017)
Figure 2016 Global Cancer Supportive Care Medicine Capacity Market Share by Region
Table Global Cancer Supportive Care Medicine Production by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Production (K Pcs) by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Production Market Share by Region (2012-2017)
Figure 2016 Global Cancer Supportive Care Medicine Production Market Share by Region
Table Global Cancer Supportive Care Medicine Revenue (Million USD) by Region (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue Market Share by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Revenue Market Share by Region (2012-2017)
Table 2016 Global Cancer Supportive Care Medicine Revenue Market Share by Region
Figure Global Cancer Supportive Care Medicine Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) Market by Region (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption Market Share by Region (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Region (2012-2017)
Figure 2016 Global Cancer Supportive Care Medicine Consumption (K Pcs) Market Share by Region
Table North America Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Cancer Supportive Care Medicine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Cancer Supportive Care Medicine Production (K Pcs) by Type (2012-2017)
Table Global Cancer Supportive Care Medicine Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Supportive Care Medicine by Type (2012-2017)
Figure 2016 Production Market Share of Cancer Supportive Care Medicine by Type
Table Global Cancer Supportive Care Medicine Revenue (Million USD) by Type (2012-2017)
Table Global Cancer Supportive Care Medicine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Supportive Care Medicine by Type (2012-2017)
Figure 2016 Revenue Market Share of Cancer Supportive Care Medicine by Type
Table Global Cancer Supportive Care Medicine Price (USD/Pcs) by Type (2012-2017)
Figure Global Cancer Supportive Care Medicine Production Growth by Type (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) by Application (2012-2017)
Table Global Cancer Supportive Care Medicine Consumption Market Share by Application (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Applications (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Application in 2016
Table Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Helsinn Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Helsinn Healthcare Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Johnson &Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson &Johnson Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Merck Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Merck Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Heron Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heron Therapeutics Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table TESARO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TESARO Cancer Supportive Care Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TESARO Cancer Supportive Care Medicine Production Growth Rate (2012-2017)
Figure TESARO Cancer Supportive Care Medicine Production Market Share (2012-2017)
Figure TESARO Cancer Supportive Care Medicine Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Supportive Care Medicine
Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine
Figure Cancer Supportive Care Medicine Industrial Chain Analysis
Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2016
Table Major Buyers of Cancer Supportive Care Medicine
Table Distributors/Traders List
Figure Global Cancer Supportive Care Medicine Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Supportive Care Medicine Price (Million USD) and Trend Forecast (2017-2022)
Table Global Cancer Supportive Care Medicine Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Cancer Supportive Care Medicine Production Market Share Forecast by Region (2017-2022)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Cancer Supportive Care Medicine Consumption Market Share Forecast by Region (2017-2022)
Figure North America Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Cancer Supportive Care Medicine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Cancer Supportive Care Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Cancer Supportive Care Medicine Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Cancer Supportive Care Medicine Production (K Pcs) Forecast by Type (2017-2022)
Table Global Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Supportive Care Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Supportive Care Medicine Price Forecast by Type (2017-2022)
Table Global Cancer Supportive Care Medicine Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Cancer Supportive Care Medicine Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source